7500 Participants Needed

Community-Based COVID-19 Testing Strategies for COVID-19

(CO-CREATE-Ex Trial)

ML
CP
BR
LL
Overseen ByLouise Laurent, MD/PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Diego

Trial Summary

What is the purpose of this trial?

Throughout the Coronavirus disease (COVID-19) pandemic, rates of COVID-19 have been persistently high in San Diego County's central and southern communities near the United States/Mexico border. These regions predominantly house Latino residents, the ethnic minority community most impacted by COVID-19 in San Diego. In the Phase I project, University of California, San Diego (UCSD) partnered with San Ysidro Health (SYH) and the Global Action Research Center, to co-create and demonstrate the impact of a COVID-19 testing program in San Ysidro, one of the most impacted areas from COVID-19 in San Diego County. To date, the project tested \>10,000 community members (92% Latino) and received requests to scale-out the testing program to additional primary care clinic sites. In this Phase III project, Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences (CO-CREATE-Ex) will extend work with the Phase I community and clinical partners to refine, specify, implement, and evaluate an implementation strategy bundle that optimizes COVID-19 testing, expanding beyond current polymerase chain reaction (PCR) testing to FDA-authorized COVID-19 rapid antigen testing.

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, but please check with the trial coordinators for confirmation.

What data supports the idea that Community-Based COVID-19 Testing Strategies for COVID-19 is an effective treatment?

The available research shows that Community-Based COVID-19 Testing Strategies, such as walk-up no-cost testing and community health worker-facilitated testing, are effective because they make testing more accessible, especially in underserved and remote communities. For example, the decentralised point-of-care testing model has been successfully implemented in remote Aboriginal and Torres Strait Islander communities in Australia, helping to address testing access issues. Additionally, home-based testing supported by community health workers has shown potential to reduce healthcare disparities in rural Native American and Latino communities in the U.S. These strategies help ensure that more people can get tested, which is crucial for controlling the spread of COVID-19.12345

What safety data exists for community-based COVID-19 testing strategies?

The safety data for community-based COVID-19 testing strategies, including CHW-led initiatives and no-cost testing options, is not explicitly detailed in the provided research. However, the studies highlight the importance of community-centered approaches, the role of CHWs in promoting health equity, and the potential benefits of decentralized testing models. These strategies aim to improve access to testing in underserved communities, suggesting a focus on safety and effectiveness in these contexts.23567

Is the treatment involving community health workers and free COVID-19 testing strategies promising?

Yes, this treatment is promising because it makes COVID-19 testing more accessible and convenient for communities. Community health workers help guide people through testing and provide health advice, which can build trust and encourage more people to get tested. Free testing options, like walk-up sites and vending machines with self-testing kits, make it easier for everyone to get tested, especially in areas where healthcare access is limited. This approach can help reduce health disparities and ensure more people know their COVID-19 status, which is important for controlling the spread of the virus.23456

Research Team

LL

Louise Laurent, MD/PhD

Principal Investigator

University of California, San Diego

Eligibility Criteria

This trial is for people who are patients at select San Ysidro Health clinics or live nearby in areas like San Ysidro and Chula Vista. Participants must speak English or Spanish. It's not open to those unable to consent, institutionalized for psychiatric reasons, developmental delays, or criminal activity.

Inclusion Criteria

You are a patient at specific clinics or live near certain community clinics.
I can communicate in English or Spanish.

Exclusion Criteria

You are living in a specialized facility for a mental health condition, have a developmental delay, or have been involved in criminal activities.
I am unable to understand and give consent for treatment.

Treatment Details

Interventions

  • Community Health Worker (CHW) leading testing navigation and general preventive care reminders
  • COVID-19 walk-up, on-site testing strategy
  • No-cost self-testing kit vending machines
Trial OverviewThe study tests a COVID-19 rapid evaluation and testing strategy led by Community Health Workers. It includes walk-up on-site testing, reminders about preventive care, and access to no-cost self-testing kit vending machines.
Participant Groups
4Treatment groups
Experimental Treatment
Placebo Group
Group I: San Ysidro Health Center - Logan HeightsExperimental Treatment2 Interventions
A vending machine and Community Health Worker (CHW) providing education will be available at Logan Heights
Group II: San Ysidro Health Center - Lincoln ParkExperimental Treatment2 Interventions
A vending machine and Community Health Worker (CHW) providing education will be available at Lincoln Park
Group III: San Ysidro Health Center - Chula VistaExperimental Treatment2 Interventions
A vending machine and Community Health Worker (CHW) providing education will be available at Chula Vista
Group IV: San Ysidro Health Center - Main ClinicPlacebo Group3 Interventions
At the main clinic all 3 strategies will be available: walk-up testing, vending machine, and Community Health Worker (CHW) providing education.

Community Health Worker (CHW) leading testing navigation and general preventive care reminders is already approved in United States for the following indications:

🇺🇸
Approved in United States as Community Health Worker-led testing navigation for:
  • COVID-19 testing navigation
  • General preventive care reminders

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials
1,215
Recruited
1,593,000+

San Ysidro Health Center

Collaborator

Trials
7
Recruited
9,600+

Findings from Research

Community health workers (CHWs) are being recognized for their potential to enhance health outcomes for vulnerable populations and to bridge clinical and community health services, as demonstrated by initiatives in Massachusetts.
Three key initiatives in Massachusetts include state certification for CHWs, integrated chronic disease programs, and a pilot program to evaluate the financial benefits of community-based prevention, which could inform health care reform across the country.
Community Health Worker Integration in Health Care, Public Health, and Policy: A Partnership Model.Wilkinson, GW., Mason, T., Hirsch, G., et al.[2019]
This study aims to develop and test community-centered COVID-19 testing strategies, including no-cost walk-up testing, community health worker-facilitated care, and vending machines for self-testing kits, involving 7,500 participants across four clinics over 18 months.
The implementation will be guided by a co-designed Theory of Change and the PRISM model, with a focus on evaluating both quantitative and qualitative data to optimize testing strategies and ensure they are sustainable and equitable for the community.
Community-engaged optimization of COVID-19 rapid evaluation and testing experiences: roll-out implementation optimization trial.Stadnick, NA., Laurent, LC., Cain, KL., et al.[2023]
The COVID-19 pandemic has led to over 37 million cases and 1 million deaths, highlighting the urgent need for accessible testing, especially in vulnerable communities with limited healthcare access.
A decentralized point-of-care testing model using the GeneXpert platform has been successfully implemented in remote Australian communities, suggesting it could be an effective strategy for improving COVID-19 testing access in socially vulnerable areas worldwide.
A decentralised point-of-care testing model to address inequities in the COVID-19 response.Hengel, B., Causer, L., Matthews, S., et al.[2022]

References

Community Health Worker Integration in Health Care, Public Health, and Policy: A Partnership Model. [2019]
Community-engaged optimization of COVID-19 rapid evaluation and testing experiences: roll-out implementation optimization trial. [2023]
A decentralised point-of-care testing model to address inequities in the COVID-19 response. [2022]
Exploring digital health interventions to support community health workers in low-and-middle-income countries during the COVID-19 pandemic: a scoping review protocol. [2021]
A pragmatic randomized trial of home-based testing for COVID-19 in rural Native American and Latino communities: Protocol for the "Protecting our Communities" study. [2023]
Insights on COVID-19 From Community Health Worker State Leaders. [2022]
Community health workers' attitudes, practices and perceptions towards the COVID-19 pandemic in brazilian low-income communities. [2021]